Subcutaneous Implantable Defibrillators Market

The subcutaneous implantable cardioverter defibrillators (SICD) is an alternative to the transvenous ICD for the prevention of sudden cardiac death (SCD).
Subcutaneous Implantable Defibrillators Market contains market size and forecasts of Subcutaneous Implantable Defibrillators in global, including the following market information:
Global Subcutaneous Implantable Defibrillators Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Subcutaneous Implantable Defibrillators Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Subcutaneous Implantable Defibrillators companies in 2021 (%)
The global Subcutaneous Implantable Defibrillators market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Ventricular Tachycardia Subcutaneous Implantable Defibrillators Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Subcutaneous Implantable Defibrillators include Mayo Clinic, MicroPort Scientific, MRI Interventions, Medtronic, Imricor, Boston Scientific and LivaNova, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Subcutaneous Implantable Defibrillators manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Subcutaneous Implantable Defibrillators Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Subcutaneous Implantable Defibrillators Market Segment Percentages, by Type, 2021 (%)
Ventricular Tachycardia Subcutaneous Implantable Defibrillators
Hypertrophic Cardiomyopathy Subcutaneous Implantable Defibrillators
Ventricular Dysplasia Subcutaneous Implantable Defibrillators
Others
Global Subcutaneous Implantable Defibrillators Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Subcutaneous Implantable Defibrillators Market Segment Percentages, by Application, 2021 (%)
Hospital
Ambulatory Surgical Centers
Others
Global Subcutaneous Implantable Defibrillators Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Subcutaneous Implantable Defibrillators Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Subcutaneous Implantable Defibrillators revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Subcutaneous Implantable Defibrillators revenues share in global market, 2021 (%)
Key companies Subcutaneous Implantable Defibrillators sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Subcutaneous Implantable Defibrillators sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mayo Clinic
MicroPort Scientific
MRI Interventions
Medtronic
Imricor
Boston Scientific
LivaNova